Company: SHPH
Filing Date: 2025-09-17
Form Type: 8-K
Source: 0001493152-25-013890
Chunk: 0

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-09-17
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.

On
September 11, 2025, Joseph Tung resigned as a director of Shuttle Pharmaceuticals Holdings, Inc.

Mr.
Tung’s resignation was not the result of any disagreement that would require disclosure under Item 5.02(a) of Form 8-K.

   2  

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

  SHUTTLE                                                      
  Dated:                                                       
  By:                                 /s/                      
  Name:                               Christopher              
  Title:                              Interim                  

   3